Company intelligence / Profile preview

Diomede Sciences

London, Greater London, UKdiomedescience.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Diomede Sciences Ltd is a recently incorporated UK-based biotech/research company. It appears to be associated with or possibly the parent of Seldovia Therapeutics, which develops assets for pediatric rare cancers at the pre-clinical stage. No clinical results are publicly available yet.

Therapeutic areas
Oncology
Modalities
Not explicitly stated; likely includes research modalities relevant to pediatric rare cancers and biotech R&D, but specifics are not available in the search results.
Industry
Biotech

Beyond the preview

Go deeper on Diomede Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diomede Sciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call